These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The acute effect of phenylpropanolamine and brompheniramine on blood pressure in controlled hypertension: a randomized double-blind crossover trial. Petrulis AS, Imperiale TF, Speroff T. J Gen Intern Med; 1991 Feb; 6(6):503-6. PubMed ID: 1684991 [Abstract] [Full Text] [Related]
12. The effect of multiple doses of phenylpropanolamine on the blood pressure of patients whose hypertension was controlled with beta blockers. O'Connell MB, Gross CR. Pharmacotherapy; 1991 Feb; 11(5):376-81. PubMed ID: 1684039 [Abstract] [Full Text] [Related]
13. Influences of urinary pH on the pharmacokinetics of three amphetamine-type stimulants using a new high-performance liquid chromatographic method. Wang L, Feng F, Wang XQ, Zhu L. J Pharm Sci; 2009 Feb; 98(2):728-38. PubMed ID: 18481797 [Abstract] [Full Text] [Related]
17. Serum concentrations of phenylpropanolamine and associated effects on blood pressure in normotensive subjects: a pilot-study. Dowse R, Scherzinger SS, Kanfer I. Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):205-10. PubMed ID: 2194987 [Abstract] [Full Text] [Related]
18. Pharmacokinetics and pharmacodynamic effects of the angiotensin II antagonist valsartan at steady state in healthy, normotensive subjects. Müller P, Flesch G, de Gasparo M, Gasparini M, Howald H. Eur J Clin Pharmacol; 1997 May; 52(6):441-9. PubMed ID: 9342579 [Abstract] [Full Text] [Related]